The Harrington Discovery Institute at University Hospitals and the American Society for Clinical Investigation have awarded Dr. Owen Witte(Link is external) (Link opens in new window) with the twelfth ...

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

"I thought there could be an easier way to make balloon arches for parties and special events," said an inventor, from ...

Phase III REMIX-1 and REMIX-2 trials demonstrated that remibrutinib, an oral BTK inhibitor, significantly reduced chronic ...

The fireside chat will be webcast live and may be accessed via a link in the Investors section of the Nurix website. The archived webcast will be available for 30 days after the event. About Nurix ...

Acute GvHD: Since ibrutinib has inhibitory effects on both, BTK and ITK, a preclinical study determined the ability of ibrutinib to target donor-derived T-cells in an aGvHD model. For exclusion of ...

Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, Michigan 49503, United States International Center for Polyamine Disorders, Grand ...

Within the BTK market, we continue to strengthen ... In terms of zani, this is actually design as you pointed out, the third arm, which you mentioned is the combination of the tisle plus zanib ...

“BRUKINSA is now the unequivocal leader in new CLL patient starts in the U.S., holds the broadest label of any BTK inhibitor and serves as the cornerstone of our hematology franchise, showing ...

Oyler, Co-Founder, Chairman, and CEO at BeiGene. “BRUKINSA is now the unequivocal leader in new CLL patient starts in the U.S., holds the broadest label of any BTK inhibitor and serves as the ...

WICHITA, Kan. (KSNW) – It was 20 years ago today that BTK was arrested in Park City. This February 2005 file photo released by the Sedgwick County Sheriff’s Office shows the booking photo of ...